1. Home
  2. ELV vs XNCR Comparison

ELV vs XNCR Comparison

Compare ELV & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elevance Health Inc.

ELV

Elevance Health Inc.

HOLD

Current Price

$375.10

Market Cap

76.6B

Sector

Health Care

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$13.95

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELV
XNCR
Founded
1944
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.6B
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ELV
XNCR
Price
$375.10
$13.95
Analyst Decision
Buy
Buy
Analyst Count
17
10
Target Price
$388.69
$22.78
AVG Volume (30 Days)
1.4M
751.8K
Earning Date
01-28-2026
11-05-2025
Dividend Yield
1.88%
N/A
EPS Growth
N/A
N/A
EPS
24.39
N/A
Revenue
$194,820,000,000.00
$150,132,000.00
Revenue This Year
$13.22
$18.81
Revenue Next Year
$3.49
N/A
P/E Ratio
$14.91
N/A
Revenue Growth
11.96
38.16
52 Week Low
$273.71
$6.92
52 Week High
$458.75
$24.66

Technical Indicators

Market Signals
Indicator
ELV
XNCR
Relative Strength Index (RSI) 73.09 33.73
Support Level $345.01 $14.97
Resistance Level $346.61 $15.42
Average True Range (ATR) 7.83 0.69
MACD 1.90 -0.28
Stochastic Oscillator 97.82 1.59

Price Performance

Historical Comparison
ELV
XNCR

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: